[go: up one dir, main page]

TR201100152A2 - Effervescent compositions containing amlodipine. - Google Patents

Effervescent compositions containing amlodipine.

Info

Publication number
TR201100152A2
TR201100152A2 TR2011/00152A TR201100152A TR201100152A2 TR 201100152 A2 TR201100152 A2 TR 201100152A2 TR 2011/00152 A TR2011/00152 A TR 2011/00152A TR 201100152 A TR201100152 A TR 201100152A TR 201100152 A2 TR201100152 A2 TR 201100152A2
Authority
TR
Turkey
Prior art keywords
compositions containing
effervescent compositions
containing amlodipine
amlodipine
effervescent
Prior art date
Application number
TR2011/00152A
Other languages
Turkish (tr)
Inventor
Bi̇lgi̇ç Mahmut
Original Assignee
Bi̇lgi̇ç Mahmut
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bi̇lgi̇ç Mahmut filed Critical Bi̇lgi̇ç Mahmut
Priority to TR2011/00152A priority Critical patent/TR201100152A2/en
Priority to PCT/TR2012/000002 priority patent/WO2012093971A2/en
Publication of TR201100152A2 publication Critical patent/TR201100152A2/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4422—1,4-Dihydropyridines, e.g. nifedipine, nicardipine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0007—Effervescent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

Mevcut buluş, amlodipin veya farmasötik açıdan uygun herhangi bir türevini içeren stabilitesi geliştirilmiş, kullanımı kolay efervesan formülasyonlara ve bu formülasyonun hipertansiyon tedavisinde kullanımına ilişkindir.The present invention relates to easy-to-use effervescent formulations having improved stability, including amlodipine or any pharmaceutically acceptable derivative thereof, and to the use thereof in the treatment of hypertension.

TR2011/00152A 2011-01-06 2011-01-06 Effervescent compositions containing amlodipine. TR201100152A2 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
TR2011/00152A TR201100152A2 (en) 2011-01-06 2011-01-06 Effervescent compositions containing amlodipine.
PCT/TR2012/000002 WO2012093971A2 (en) 2011-01-06 2012-01-06 Effervescent compositions comprising amlodipine

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
TR2011/00152A TR201100152A2 (en) 2011-01-06 2011-01-06 Effervescent compositions containing amlodipine.

Publications (1)

Publication Number Publication Date
TR201100152A2 true TR201100152A2 (en) 2012-07-23

Family

ID=45855989

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2011/00152A TR201100152A2 (en) 2011-01-06 2011-01-06 Effervescent compositions containing amlodipine.

Country Status (2)

Country Link
TR (1) TR201100152A2 (en)
WO (1) WO2012093971A2 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104055742B (en) * 2014-02-13 2018-01-19 合肥九研医药科技开发有限公司 Levamlodipine besylate pharmaceutical composition and preparation method thereof
CN105310992B (en) * 2015-10-16 2018-11-09 施慧达药业集团(吉林)有限公司 The tablet composition of Levamlodipine besylate salt hydrate, the tablet being made from it and related manufacturing processes

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK161312C (en) 1982-03-11 1991-12-09 Pfizer CHANGES FOR THE PREPARATION FOR THE PREPARATION OF 2-Amino-CO-Methyl-4-Methyl-4-Methyl-4-Methyl-4-Methyl-4-Methyl-4-Methyl-2-D-Hydroxy
IT1255792B (en) * 1992-08-05 1995-11-16 Bayer Italia Spa PHARMACEUTICAL COMPOSITIONS FOR THE ORAL ADMINISTRATION OF DIHYDROPYRIDINS IN THE FORM OF DRINK
IE940292A1 (en) * 1994-04-06 1995-10-18 Elan Corp Plc Biodegradable microcapsules and method for their manufacture
AU3574500A (en) * 1999-03-25 2000-10-16 Yuhan Corporation Rapidly disintegrable tablet for oral administration
US20080063710A1 (en) * 2004-12-28 2008-03-13 Eisai R&D Management Co., Ltd. Rapidly Disintegrating Tablet and Production Method Thereof
EP2575757A1 (en) * 2010-06-03 2013-04-10 Mahmut Bilgic Water soluble formulation comprising a combination of amlodipine and a statin

Also Published As

Publication number Publication date
WO2012093971A2 (en) 2012-07-12
WO2012093971A3 (en) 2012-09-20

Similar Documents

Publication Publication Date Title
CY1122853T1 (en) SOLID FORMULATIONS OF LINACLOTIDE
DOP2011000354A (en) SUBLINGUAL COMPOSITIONS OF DEXMEDETOMIDINE AND METHODS OF USE OF THEM
PH12015501439A1 (en) Oral care products comprising zinc oxide and trimethylglycine
EA201390803A1 (en) Bromodomain inhibitors and their use
MX2011003473A (en) Oral care compositions.
MA33803B1 (en) BENZODIAZEPINE BROMODOMAINE INHIBITOR
EP2550954A4 (en) VASELINE-TYPE COMPOSITION AND COSMETIC PREPARATION
EA201270741A1 (en) ORAL COMPOSITIONS AND LIPOPHYL SALTS OF METHylNALTREX
MX2019012939A (en) Linaclotide-containing formulations for oral administration.
PH12012501522A1 (en) Oral care compositions
PH12012501620A1 (en) Oral care compositions
EA201390799A1 (en) TRIAZOLOPRYRIDINS
EA201590491A1 (en) IMMUNOGENIC COMPOSITION
TR201906685T4 (en) Pharmaceutical composition containing crystalline macitentane.
TR201009394A2 (en) Improved montelukast formulations.
MA32321B1 (en) Brin-4-en-21, 17-lactone substituted in the c-ring and the pharmaceutical preparations it contains
UA109804C2 (en) 2-methoxypyridine-4-yl derivatives
TR201803451T4 (en) OLMESARTAN FORMULATIONS.
TR201100152A2 (en) Effervescent compositions containing amlodipine.
TR200909785A1 (en) Pharmaceutical compositions containing cefdinir as the active agent.
EA201291420A1 (en) ORAL MEDICAL FORMS CONTAINING LERCANIDIPIN AND ENALAPRIL AND THEIR PHARMACEUTICALLY ACCEPTABLE SALTS
TR201005327A2 (en) Synergistic pharmaceutical formulations.
MX2013008559A (en) Leptin derivatives.
MY154024A (en) Oral care compositions and methods
TR201009399A2 (en) Rapidly soluble effervescent rosuvastatin formulations.